Michel Ronc
Chairman at Freshmile SAS
Profile
Michel Ronc is currently the Chairman of Freshmile SAS and Director at Domain Therapeutics SA since 2008.
He previously worked as the President & Chief Executive Officer of Elf Technologies, Inc. from 1984 to 1991.
He also worked as a Manager-Research & Development at Total Holdings SAS and as a Partner at Demeter Partners SA from 2005 to 2013.
Additionally, he served as a Director at Polyplus-transfection SA and a Consultant at TotalEnergies SE.
Dr. Ronc holds a doctorate degree from McGill University and an undergraduate degree from Ecole Nationale Superieure de Genie Industriel.
Michel Ronc active positions
| Companies | Position | Start |
|---|---|---|
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Director/Board Member | 01/01/2008 |
Freshmile SAS
 Freshmile SAS Packaged SoftwareTechnology Services Freshmile SAS offers charging services for electric vehicles. The company was founded by Arnaud Morais headquartered in Entzheim, France. | Chairman | - |
Former positions of Michel Ronc
| Companies | Position | End |
|---|---|---|
Demeter Partners SA
 Demeter Partners SA Investment ManagersFinance Demeter Partners SA (Demeter Partners) is a French private equity firm which was founded in 2005 by Sophie Paturle-Guesnerot and Stéphane Villecroze and is majority-owned by the management team. Headquartered in Paris with an additional office in Madrid, Demeter Partners has partnerships with English, German and Spanish funds which are involved in their sectors and are also members of international networks of investors specialized in 'clean technologies'. The firm manages the Demeter Fund, sponsored by the Caisse des Dépôts (CDC Entreprises) and the Institut Français du Pétrole (French Petroleum Institute) for institutional investors including life insurance companies, health insurance companies, pension funds and sophisticated private investors. | Director/Board Member | 01/03/2013 |
Elf Technologies, Inc.
 Elf Technologies, Inc. Investment ManagersFinance Part of TotalEnergies SE, Elf Technologies, Inc. is an American company. | Chief Executive Officer | 01/01/1991 |
| TOTALENERGIES SE | Corporate Officer/Principal | - |
Total Holdings SAS
 Total Holdings SAS Wholesale DistributorsDistribution Services Total Holdings SAS provides oil refining and marketing services. The company was founded on October 10, 1955 and is headquartered in Courbevoie, France. | Chief Tech/Sci/R&D Officer | - |
Polyplus-transfection SA
 Polyplus-transfection SA BiotechnologyHealth Technology Polyplus-transfection SA develops and sells solutions for the delivery of nucleic acids in research, bio production, and therapeutics. Its products are transfection reagents and trademarks, mainly for gene and cell therapies. The company was founded by Jean-Paul Behr, Anne-Lise Monjanel, Joelle Bloch, and Patrick Metz in January 2001 and is headquartered in Illkirch-Graffenstaden, France. | Director/Board Member | - |
Training of Michel Ronc
| McGill University | Doctorate Degree |
| Ecole Nationale Superieure de Genie Industriel | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TOTALENERGIES SE | Energy Minerals |
| Private companies | 6 |
|---|---|
Total Holdings SAS
Total Holdings SAS Wholesale DistributorsDistribution Services Total Holdings SAS provides oil refining and marketing services. The company was founded on October 10, 1955 and is headquartered in Courbevoie, France. | Distribution Services |
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
Demeter Partners SA
Demeter Partners SA Investment ManagersFinance Demeter Partners SA (Demeter Partners) is a French private equity firm which was founded in 2005 by Sophie Paturle-Guesnerot and Stéphane Villecroze and is majority-owned by the management team. Headquartered in Paris with an additional office in Madrid, Demeter Partners has partnerships with English, German and Spanish funds which are involved in their sectors and are also members of international networks of investors specialized in 'clean technologies'. The firm manages the Demeter Fund, sponsored by the Caisse des Dépôts (CDC Entreprises) and the Institut Français du Pétrole (French Petroleum Institute) for institutional investors including life insurance companies, health insurance companies, pension funds and sophisticated private investors. | Finance |
Elf Technologies, Inc.
Elf Technologies, Inc. Investment ManagersFinance Part of TotalEnergies SE, Elf Technologies, Inc. is an American company. | Finance |
Freshmile SAS
Freshmile SAS Packaged SoftwareTechnology Services Freshmile SAS offers charging services for electric vehicles. The company was founded by Arnaud Morais headquartered in Entzheim, France. | Technology Services |
Polyplus-transfection SA
Polyplus-transfection SA BiotechnologyHealth Technology Polyplus-transfection SA develops and sells solutions for the delivery of nucleic acids in research, bio production, and therapeutics. Its products are transfection reagents and trademarks, mainly for gene and cell therapies. The company was founded by Jean-Paul Behr, Anne-Lise Monjanel, Joelle Bloch, and Patrick Metz in January 2001 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
- Stock Market
- Insiders
- Michel Ronc
